Exact Mass: 517.2132

Exact Mass Matches: 517.2132

Found 500 metabolites which its exact mass value is equals to given mass value 517.2132, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pyronaridine

4-({7-chloro-2-methoxy-1H,5H-benzo[b]1,5-naphthyridin-10-yl}imino)-2,6-bis(pyrrolidin-1-ylmethyl)cyclohexa-2,5-dien-1-one

C29H32ClN5O2 (517.2244)

Pyronaridine belongs to the family of Naphthyridines. These are compounds containing a naphthyridine moeity, a naphthalene in which a carbon atom has been replaced by a nitrogen in each of the two rings. The naphthyridine skeleton can also be described as an assembly two fused pyridine rings, which do not share their nitrogen atom.

Propafenone glucuronide

3,4,5-trihydroxy-6-({1-[2-(3-phenylpropanoyl)phenoxy]-3-(propylamino)propan-2-yl}oxy)oxane-2-carboxylic acid

C27H35NO9 (517.2312)

Ejap 7

[3R-(3alpha,5beta,5aalpha,6alpha,9alpha,9aalpha,10R*)]-6,10-bis(Acetyloxy)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5-yl ester 3-pyridinecarboxylic acid

C27H35NO9 (517.2312)

(3aS)-5c-[(1R,2E,4E)-6-hydroxy-1,3-dimethyl-6-((E)-1-methyl-2,4-dioxo-pyrrolidin-3-ylidene)-hexa-2,4-dienyl]-2c,6t,9a-trimethyl-8-oxo-(9at)-octahydro-3ar,7c-epioxido-furo[3,2-b]oxocine-3c-carboxylic acid methyl ester|antibiotic Bu-2313-A|N-methyl-nocamycin-I

(3aS)-5c-[(1R,2E,4E)-6-hydroxy-1,3-dimethyl-6-((E)-1-methyl-2,4-dioxo-pyrrolidin-3-ylidene)-hexa-2,4-dienyl]-2c,6t,9a-trimethyl-8-oxo-(9at)-octahydro-3ar,7c-epioxido-furo[3,2-b]oxocine-3c-carboxylic acid methyl ester|antibiotic Bu-2313-A|N-methyl-nocamycin-I

C27H35NO9 (517.2312)

Lys Asn Gln Glu

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]butanamido]pentanedioic acid

C20H35N7O9 (517.2496)

Val Gly Asp Asp Ile

C21H35N5O10 (517.2384)

Arg Asp Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-methylbutanamido]pentanedioic acid

C20H35N7O9 (517.2496)

Gln Asp Leu Glu

C21H35N5O10 (517.2384)

Val Asn Ala Gln Ser

C20H35N7O9 (517.2496)

Arg Ile Asp Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-carboxypropanamido]butanedioic acid

C20H35N7O9 (517.2496)

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]acetic acid

C23H31N7O7 (517.2285)

Gln Tyr Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H31N7O7 (517.2285)

Gln Tyr His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C23H31N7O7 (517.2285)

C25H31N3O9 (517.206)

Hydroxyergometrine glucoronide M2

C25H31N3O9 (517.206)

4-({7-chloro-2-methoxy-1H,5H-benzo[b]1,5-naphthyridin-10-yl}imino)-2,6-bis(pyrrolidin-1-ylmethyl)cyclohexa-2,5-dien-1-one

C29H32ClN5O2 (517.2244)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

LPS 18:4

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphoserine

C29H31N3O4S (517.2035)

Dolichyl diphosphate trianion

C25H43O7P2-3 (517.2484)

(2E)-3-ethyl-2-[(E)-3-(3-ethyl-4,5-diphenyl-1,3-thiazol-3-ium-2-yl)prop-2-enylidene]benzo[g][1,3]benzothiazole

C33H29N2S2+ (517.1772)

2-amino-3-[hydroxy-[2-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C24H40NO9P (517.2441)

Phaseolotoxin

C14H32N9O8PS (517.1832)

A tripeptide resulting from the formal condensation of the carboxy group of N(5)-[amino(sulfoamino)phosphoryl]-L-ornithine with the N-terminal amino group of L-alanyl-L-arginine. A toxin produced by cultured Pseudomonas syringae, the causal agent of halo blight disease in bean plants.

ST 25:6;O7;Gly

C27H35NO9 (517.2312)

ST 19:5;O4;HexNAc

C27H35NO9 (517.2312)

ST 21:3;O7;Tau

C23H35NO10S (517.1982)

ST 22:2;O6;Tau

C24H39NO9S (517.2345)

ST 25:7;O4;Tau

C27H35NO7S (517.2134)

AZD3147

3,6-dihydroxy-3-[({4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl}oxy)carbonyl]-6-methylheptanoic acid

C27H35NO9 (517.2312)

(1r,2s,5r,6s,14s,17s,18s)-10-{[(2r)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-17-methyl-9,12-dioxo-15-oxapentacyclo[12.6.0.0¹,⁶.0²,¹⁸.0⁸,¹³]icosa-8(13),10-diene-5-carboxylic acid

(1r,2s,5r,6s,14s,17s,18s)-10-{[(2r)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-17-methyl-9,12-dioxo-15-oxapentacyclo[12.6.0.0¹,⁶.0²,¹⁸.0⁸,¹³]icosa-8(13),10-diene-5-carboxylic acid

C26H31NO8S (517.177)

4-[(7s,8r)-8-(hydroxymethyl)-4-methoxy-16,16,19-trimethyl-6,17-dioxa-11-azapentacyclo[10.8.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]icosa-1(12),2(10),3,5(9),13(18),14,19-heptaen-7-yl]-2,6-dimethoxyphenol

C30H31NO7 (517.21)

(9s,9ar)-9-hydroxy-9-{[(1r,4r)-3-hydroxy-1-isopropyl-1-methoxy-6-oxo-4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2,2-dimethyl-1h,9ah-imidazo[1,2-a]indol-3-one

C28H31N5O5 (517.2325)

(3r)-3,6-dihydroxy-3-({[(2s,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl]oxy}carbonyl)-6-methylheptanoic acid

C27H35NO9 (517.2312)

(2s,3r)-2,3-dihydroxy-3-({[(2s,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl]oxy}carbonyl)-6-methylheptanoic acid

C27H35NO9 (517.2312)

(2r,3s,4s,5s,6s,7s,8r,9e)-11-(6-amino-2-hydroxy-3-methyl-5,8-dioxonaphthalen-1-yl)-3,5,7-trihydroxy-2,4,6,8,10-pentamethyl-11-oxoundec-9-enoic acid

C27H35NO9 (517.2312)